Loss of Muscleblind-like 1 (Mbnl1) is known to alter Clc-1 splicing to result in myotonia. Mbnl1
Introduction
Myotonic Dystrophy type 1 (DM1) is an autosomal dominant disorder resulting from the expansion of a non-coding CTG repeat sequence located in the 3′ untranslated region of DMPK (Brook et al., 1992; Harper, 2009 ). In DM1, expanded CUG repeat RNAs (CUGexp) aberrantly sequester and disable the muscleblind-like (MBNL) family of splice regulators (Fardaei et al., 2002; Dansithong et al., 2005) . Significantly, either CUGexp expression or the depletion of Mbnl1 in mouse models has been shown to result in Clc-1 RNA splice defects and myotonia (Mankodi et al., 2002; Kanadia et al., 2003) . This and other lines of evidence have lead DM1 to be considered as a spliceopathy (Ranum and Cooper, 2006) . Other studies have implicated the muscleblind proteins in RNA transport, protein secretion and polyadenylation (Adereth et al., 2005; Wang et al., 2012; Batra et al., 2014) . However the mechanisms whereby the Mbnl proteins mediate these functions and the role of these novel functional aspects of the Mbnl proteins in disease initiation has yet to be fully understood. In this study we show that the coordinate loss of Mbnl1 and Mbnl3 results in a synergistic enhancement of myotonia and a sharp increase in the number EBioMedicine 2 (2015) [1034] [1035] [1036] [1037] [1038] [1039] [1040] [1041] [1042] [1043] [1044] [1045] [1046] [1047] of muscle fibers with extremely low chloride currents. We demonstrate that this synergism does not result from an enhancement in Clc-1 splice errors, alterations in polyA site selection or Clc-1 localization but rather reflects the aberrant accumulation of Clc-1 mRNA on monosomes and the first polysomes in muscles lacking Mbnl1 and Mbnl3. The observed Clc-1 translation errors reflect the ability of Mbnl1 and Mbnl3 to act as adaptors, recruiting Hsp70 and eEF1A, to Clc-1 mRNA engaged with ribosomes to facilitate translation. These results therefore demonstrate that Clc-1 RNA translation defects work coordinately with Clc-1 splice errors to synergistically enhance myotonia in mice lacking Mbnl1 and Mbnl3. As similar defects are observed in the HSA LR DM1 mouse model, where CUGexp aggregate and disable the Mbnl proteins, this study shows that both splice errors and translational defects are required for key features of DM1 pathology to fully manifest.
Materials & Methods

Ethics Statement
All experiments were performed in accordance with the institutional guidelines of the University of Southern California, Los Angeles, University at Buffalo, Buffalo New York and the University of California, Los Angeles. The protocols were approved by the Institutional Animal Care and Use Committee at the University of Southern California, Los Angeles (Protocol number: 10347).
Muscle Physiology
Contractile properties, electromyography and muscle histology were studied using standard procedures (Reddy et al., 1996; Personius and Arbas, 1998; Personius and Sawyer, 2006) . Electrophysiological methods were similar to those described previously (DiFranco et al., 2011) . Further details for electrophysiology, solutions and data acquisition are provided in Supplementary Information.
RNA Analysis
RNA isolation, splicing assays and RT-qPCR analysis were carried out primarily as described in Dansithong et al. (2005) . Soleus polyribrosomes were prepared according to a previously described protocol (Darnell et al., 2011) with several modifications. In vitro RNA binding assays were carried out as previously described (Paul et al., 2006) with some modifications. Detailed protocols are available in Supplementary Information.
Purification and Mass Spectrometric Analysis of MBNL3 Complexes
HEK293 cell lines expressing Flag-MBNL3 were generated by transfection of a pCDNA3.1-Flag-MBNL3 vector. Experimental details, including purification and mass spectrometric analysis of MBNL3 complexes are provided in Supplementary Information.
3′RACE and PCR
For 3′RACE, total RNA was reverse transcribed using 3′RACE System for Rapid Amplification of cDNA Ends kits (Life Technologies, USA) with the adapter primer (AP-3′RACE: 5′-AAG CAG TGG TAA CAA CGC AGA  GTA CTT TTT TTT TTT TTT TTT TTT TTT TTT TTT TVN-3′) . Target cDNAs were amplified by PCR and nested PCR with gene-specific forward primers and the amplification primer (AP: 5′-AAG CAG TGG TAA CAA CGC AGA GT-3′). The relative band intensities were measured by densitometry analysis using Gene Tool (Syngene Inc., USA). To identify the Poly(A) sites, bands were excised and extracted using gel extraction kit (Qiagne, USA). Extracted DNAs were cloned into pGEM-T Easy Vector (Promega, USA) according to the manufacturer's protocol. The DNA inserts were sequenced using the customized sequencing primers, T7 and SP6 promoter sequencing primers (Integrated DNA Technologies Inc., USA). The gene-specific forward primers and sequencing primers are as listed in Table S1 .
Results
Development of Mbnl2
GT2/GT2 and Mbnl3 ΔE2 Mice
We developed 129sv Mbnl2 gene trap (Mbnl2
GT2/GT2
) mice derived from a BayGenomic ES cell line in which a retroviral β-geo gene trap is integrated downstream of Mbnl2 exon 2 (Fig. 1A-C) . Chimeric animals derived from targeted 129sv ES cells were bred to 129sv wild type animals to derive 129sv Mbnl2 +/GT2 mice. Analysis of genotype ratios of the progeny of Mbnl2 +/GT2 crosses did not reveal an Mbnl2 GT2/GT2 lethal phenotype. In the Mbnl2 GT2/GT2 mice transcription beyond the polyA site in the β-geo cassette in conjunction with the absence of the utilization of the β-geo splice acceptor site can result in the production of the normal transcript. Therefore we measured Mbnl2 levels using the MB2a monoclonal antibodies (Holt et al., 2009 ) and observe that Mbnl2 levels were decreased by~85% in Mbnl2 GT2/GT2 mice (Fig. 1D ).
In parallel experiments we developed male Mbnl3 ΔE2 and female (Poulos et al., 2013) . These authors identified a 27 kD Mbnl3 isoform (Mbnl3 27kD ), resulting from the use of a second translation start site located in Mbnl3 exon 3. In their study, deletion of Mbnl3 exon 2 resulted in the loss of the full-length Mbnl3 38kD protein and retention of the truncated Mbnl3 27kD isoform (Poulos et al., 2013) . We developed polyclonal antibodies using an Mbnl3 C-terminal peptide as previously described (Poulos et al., 2013) placenta, a tissue that expresses high levels of Mbnl3 ( Fig. 1G & H) . Previous studies have shown elevated levels of Mbnl3 mRNA in stem cells and in multiple tissues during embryogenesis with diminished expression in adult human and mouse tissues (Fardaei et al., 2002; Poulos et al., 2013 the RNA from these tissues was examined for DM1 specific splice defects in a sample set of four RNAs, Ldb3, Clc-1, mTitin and Atp2a1 (Lin et al., 2006) . In these experiments no significant change in the splicing of these RNAs in Mbnl2 GT2/GT2 and Mbnl3 ΔE2 skeletal muscles was observed when compared with wild type controls (Fig. S3) . In parallel experiments no overt changes in muscle structure or function were detected.
Mbnl3
Mbnl1
ΔE3/ΔE3
/Mbnl2 GT2/GT2 Mice Demonstrate a Lethal Phenotype
To test the combinatorial effects of dose reductions in Mbnl1 and Mbnl2 we examined the genotypes of the progeny from an Mbnl1 +/ΔE3 X Mbnl2 +/GT2 cross. Mbnl1 +/ΔE3 mice, in which a Neomycin cassette replaces Mbnl1 exon 3, are a gift of Dr. Swanson and have been previously described by Kanadia et al., (2003) . These animals were backcrossed onto a 129sv background for 4 generations prior to use in our experiments. Mbnl2 GT2/GT2 /Mbnl1 ΔE3/ΔE3 animals were not observed in the~300 progeny examined, consistent with the lethality of the Mbnl1
/Mbnl2-GT2/GT2 genotype.
Mbnl1
ΔE3/ΔE3
/Mbnl3
ΔE2 Mice Show Enhanced Myotonic Activity
In contrast to the lethal phenotype observed in the Mbnl2 GT2/GT2 / Mbnl1 ΔE3/ΔE3 animals, dual loss of Mbnl1 and Mbnl3 results in viable
Mbnl1
ΔE3/ΔE3
/Mbnl3
ΔE2 animals that demonstrate a synergistic enhancement of skeletal muscle myotonia. As reported previously for the vastus muscle, runs of myotonic activity were observed in both the EDL and soleus muscles following needle insertion in Mbnl1 ΔE3/ΔE3 mice with myotonic activity averaging at 3.07 ± 1.46 s in the EDL and 3.98 ± 2.10 s in the soleus (mean ± SEM, Tables 1 & 2) (Kanadia et al., 2003) . In striking contrast, the length of myotonic activity was four to ten folds greater in Mbnl1
/Mbnl3 ΔE2 mice with average run lengths of 17.1 ± 3.88 s in the EDL and 32.3 ± 26.7 s in the soleus (mean ± SEM, Tables 1 & 2) . The longest run of myotonic activity detected from Mbnl1 ΔE3/ΔE3 and Mbnl1-
ΔE3/ΔE3
/Mbnl3 ΔE2 mice is shown in Fig. 2A To test the effect of Mbnl dose reductions on specific force we measured maximal isometric specific force produced by the EDL muscle in wild type, Mbnl1
/Mbnl3
ΔE2 and Mbnl1
/Mbnl2 GT2/GT2 mice. In these experiments, animal weight and EDL muscle weight were similar across all experimental groups ( /Mbnl3 ΔE2 mice, respectively). Finally, no differences in the extent of muscle fatigue following 3 min of contraction at a 1/3 duty cycle was seen between genotypes further supporting limited changes in the distribution of muscle fiber-types in these genotypes ( with regions of muscle fibers containing centralized nuclei (Kanadia et al., 2003) . In contrast, muscle sections from Mbnl1
ΔE3/ΔE3
/Mbnl3 ΔE2 mice demonstrate some centralized nuclei, areas of very small atrophied fibers and regions of potential fibrosis (Fig. 2F ). Average muscle fiber perimeter was 127 ± 3, 113 ± 7, 111 ± 15, 128 ± 40, and 138 ± 9 μm for wild type, Mbnl1 
/Mbnl3
ΔE2 mice Clc-1 protein expression was examined by semi-quantitative immunoflourescence studies.
Immunoflourescence analyses were utilized, as commercially available anti-Clc-1 antibodies are unable to detect chloride channels by Western blot analyses. Clc-1 protein expression was identified by immunofluorescence using antibodies against the C terminus (CLC1 1-A; Alpha Diagnostic) and imaged by confocal microscopy. Since the intensity of Clc-1 immunofluorescence was relatively low, the confocal pin-hole was opened to 1.12 airy units to improve image brightness. Images were not deconvolved to better identify receptor localization (Fig. 2G ). The images observed using this protocol closely resemble confocal images of Ca v 1.1 and Ca v 1.2 Ca 2+ expression in skeletal muscle (Jeftinija et al., 2007) . As a first attempt to quantify Clc-1 expression, we measured CIc-1 immunofluorescence in 15 membrane regions for each confocal image (80 μm 2 ovals). The grayscale intensity of CIc-1 membrane immunolabeling was decreased in Mbnl3 ΔE2 and Mbnl1-ΔE3/ΔE3 /Mbnl3
ΔE2 muscles compared to wild type, Mbnl2 GT2/GT2 and Mbnl3 ΔE2 muscles (p b 0.001). Specifically, average gray scale values were 36 ± 3, 24 ± 1, 20 ± 1, 38 ± 3, and 39 ± 4 GSE for wild type, 
ΔE2 mice. Since the total ICl recorded from a single muscle fiber depends on its physical dimensions (length and radius), in these experiments we normalized the raw currents by both the fibers' surface area (μA/cm 2 ) and capacitance (A/F). As our previous work has shown that a large fraction of ICl arises from the T tubule system (TTS) of adult mice (DiFranco et al., 2011) , the latter normalization would take into account the contribution of the TTS to the total membrane area of a fiber. ICl records in response to the 3-pulse protocol obtained sPo: Specific maximal muscle force production and Pt: specific twitch force production. % Fatigue: The percent decrease in force production over 3 min. (*) One-way ANOVA and Student t-tests with Bonferroni correction were used to determine paired differences between Mbnl genotypes and wild type mice. (#) ANOVA on ranks with Dunn's post-hoc analysis was used for data with non-normal distribution. Bold indicates the statistically significant (p b0.05).
from a wild type (129SV) fiber are shown in Fig. 3A . These currents show the canonical features of ICl that have previously been reported for adult wild type C57BL6 mice (DiFranco et al., 2011) . Specifically, immediately following maximal activation during a long depolarization to +60 mV (pre-pulse), ICl records during test pulses show the typical inward rectification pattern with smaller steady outward currents (Fig. 3A , blue, gold, pink, and dark cyan traces) in response to depolarizing pulses, and larger transient inward currents with voltage-dependent deactivation rates (Fig. 3A , red, green, blue, orange and purple traces) in response to hyperpolarizing pulses. In the wild type 129sv fiber, the peak ICl in response to a −120 mV pulse ([peak ICl] In order to further establish the comparative differences in the functional expression of Clc-1 in Mbnl mutant mice, we investigated whether the voltage-dependence of the peak (instantaneous) and steady-state I-V plots of ICl were preserved in wild type, Mbnl1 A more comprehensive way to demonstrate the reduction in the expression of functional Clc-1 channels in Mbnl mutant muscles is to evaluate the maximal (limiting) slope conductance (gCl max ), as obtained from the instantaneous I-V plots of ICl. Fig. 3G shows that, in correspondence with the data from the previous plots, gCl max is large in wild type (7.0 ± 0.31 mS/cm 2 , or 1.39 ± 0.09 mS/μF; n = 16) and Mbnl3 ΔE2 (7.4 ± 0.27 mS/cm 2 , or 1.57 ± 0.06 mS/μF; n = 37), muscles. Nevertheless, the data on the functional expression of Clc-1 channel reported here are incompatible with the classic claim that the genesis of myotonia requires reductions in gCl larger than 70% (Furman and Barchi, 1978) . In order to examine this apparent discrepancy, we compared the frequency distribution of gCl max in fibers from the wild type and the Mbnl strains (Fig. 4) . Each dataset was fitted with a normal distribution (shown with solid lines) and for the purpose of comparison, the normal curve fitted to the data from the wild type mice is shown superimposed to the data from the Mbnl mutant strains. It can be observed that the gCl max histograms for fibers of wild type and Mbnl3 ΔE2 mice ( Fig. 4A and B) are very similar to each other, and the medians are centered at almost identical average values. These results are in agreement with both the lack of myotonia and the normal ICl in Mbnl3 ΔE2 mice. In contrast, when the data obtained from wild type and Mbnl1 ΔE3/ΔE3 mice are compared (Fig. 4C) , the average gCl max is clearly shifted to the left, and that there are a significant number of fibers with very small gCl max values that are outside the normal distribution of wild type animals. We propose that, although on-average gCl max is not drastically reduced in Mbnl1 ΔE3/ΔE3 mice, the small but significant numbers of severely affected fibers may explain the mild myotonia in these animals. This explanation is consistent with the observation that the Mbnl1
ΔE3/ΔE3
/Mbnl3 ΔE2 mice displays both much stronger myotonia and show a much more significant shift of the average gCl max to lower values (Fig. 4D) As the myotonia observed in DM1 has been hypothesized to result primarily from Clc-1 splice errors and a concomitant reduction of RNA steady-state levels due to nonsense mediated decay of aberrantly /Mbnl3 ΔE2 (C) foot muscles are shown. Leak and capacitive current components were subtracted. The holding potential was set to −20 mV, which is equal to the Nernstian chloride equilibrium potential (E Cl ). The amplitude of the first (conditioning) pulse was +80 mV; the amplitude(s) of the second pulse (test pulses) ranged from 160 to −120 mV (in 20 mV steps); the third pulse amplitude was −60 mV. (Fig. 5A) . These results were confirmed by qPCR, which showed that the steady-state mRNA levels of Clc-1 isoforms including exon 7a and exon 7 in Mbnl1 ΔE3/ΔE3 / Mbnl3 ΔE2 skeletal muscles was similar to that observed in Mbnl1 ΔE3/ ΔE3 (Fig. S5A) . To test the possibility that splice defects other than aberrant Clc-1 exon 7a inclusion are enhanced in Mbnl1 ΔE3/ΔE3 /Mbnl3 ΔE2 mice, we checked exon inclusion for all Clc-1 exons (Fig. S5B) . Additional splice defects including retention of intron 2 and inclusion of exon 8a were observed in Mbnl1 ΔE3/ΔE3 skeletal muscles (Fig. 5A ), but no enhancement of these splice errors was observed in Mbnl1 (Poulos et al., 2013) . In contrast, Mbnl1 has been shown to associate with smaller mRNP particles, but not with polysomes in HeLa cells (Onishi et al., 2008) . To clarify whether Mbnl1 associates with polysomes in mouse skeletal muscle, we performed polysome analysis using sucrose gradient fractionation. As reported for HeLa cells, we found that the majority of Mbnl1 co-fractionates with smaller mRNP particles. However in skeletal muscle Mbnl1 was also detected in polysome fractions (Fig. S6 ). This observation was confirmed by polysome disruption with EDTA treatment, which resulted in a shift of Mbnl1 in polysome factions to lower density fractions (Fig. S6 ). These data suggested that Mbnl1 and Mbnl3 might be involved in the translational regulation of Clc-1 mRNA. Polyribosomes were therefore prepared using soleus muscles dissected from wild type (n = 4), Mbnl1 ΔE3/ΔE3 (n = 5), Mbnl3 ΔE2 (n = 3) and Mbnl1
/ Mbnl3
ΔE2 (n = 3) mice on 20-50% density sucrose gradient and polyribosome profiles were analyzed by A 254 absorbance (Fig. 6A ) and nondenaturing agarose gel electrophoresis (Fig. S7) Clc-1 mRNA is highly enriched in fraction numbers 6 and 7 that correspond to monosomes and the first polysomes respectively as shown in the A 254 traces of total RNA distribution ( Fig. 6A & B) . To further test whether the Clc-1 polysome distribution pattern observed in Mbnl1 ΔE3/
ΔE3
/Mbnl3
ΔE2 mice is specific, we analyzed the Clc-1 mRNA distribution pattern subsequent to EDTA treatment by qPCR. As expected, EDTA treatment resulted in a shift of the Clc-1 mRNAs to lighter fractions by polysome disruption (Fig. 6C) . Western blot analysis did not show significant differences in Gapdh levels in the mouse genotypes studied (Fig. S8) . Consistent with this observation relative Gapdh mRNA distribution in the 16 polysome sucrose gradient fractions from wild type, Mbnl1-
ΔE3/ΔE3
, Mbnl3 ΔE2 and Mbnl1
/Mbnl3 ΔE2 skeletal muscles were not significantly different (Fig. 6D) . To determine whether the distinct Clc-1 mRNA distribution pattern in Mbnl1
/Mbnl3 ΔE2 skeletal muscles is also observed with the overexpression of CUGexp RNA in vivo, we analyzed the HSA LR mouse model for myotonic dystrophy, which expresses 250 CUG repeats located in the 3′ UTR of the human skeletal actin transgene that results in the aberrant sequestration of the Mbnl proteins (Mankodi et al., 2002; Lin et al., 2006) . As expected, we observed enhanced inclusion of Clc-1 exon 7a in HSA LR muscles when compared to wild type muscles (Fig. 6E) . However, in contrast to a 7 fold increase in Mbnl1
/Mbnl3 ΔE2 skeletal muscles (Fig. S5B) , the HSA LR muscles showed a 2.6 fold increase in the steady-state mRNA levels of the Clc-1 isoforms including exon 7a when compared to wild type muscles. Consistent with this observation, steady-state Clc-1 mRNA levels in the HSA LR skeletal muscles were reduced by~30% when compared to wild type muscles (Fig. 6F) , in contrast to the~50% reduction in Mbnl1
ΔE2 muscles (Fig. 5B) . The reduced severity of Clc-1 RNA processing defects may reflect the less than complete sequestration of the Mbnl proteins by CUGexp in the HSA LR mice. Polyribosome profiles from~2 month old wild type (n = 6) and HSA LR (n = 6) soleus muscles were analyzed by A 254 absorbance (Fig. 6G ) and relative Clc-1 mRNA distribution in each of the 16 polysome sucrose gradient fractions was analyzed by qPCR (Fig. 6H ). Similar to Mbnl1
/Mbnl3 ΔE2 skeletal muscles, Clc-1 mRNA was significantly enriched in fraction number 7 in HSA LR skeletal muscle when compared to wild type muscle (Fig. 6H ). These data strongly , Mbnl3
ΔE2
, and Mbnl1
ΔE3/ΔE3
/Mbnl3
ΔE2 soleus muscles (n = 6) were subjected to qPCR to measure Clc-1 mRNA (B) and hnRNA (C) steady-state levels. Clc-1 mRNA and hnRNA levels were normalized to that of Gapdh. Location of Clc-1 exon-exon boundary spanning primers and exon-intron boundary spanning primers used for mRNA and hnRNA level measurements are shown. PCR amplification in the absence of reverse transcriptase was used to confirm the absence of genomic DNA contaminants (Fig. S5) . Error bars represent standard error of mean (SEM). Each sample was replicated in triplicate. p-values were determined by paired student's t-test. * and *** indicates p b 0.05 and p b 0.0001, respectively. /Mbnl3 ΔE2 (n = 3) soleus muscles was fractionated by centrifugation at 40,000 rpm for 2 h at 4°C using a 20%-50% w/w linear density gradient of sucrose. A 254 traces of total RNA distributions are shown. Gradient fraction numbers, 40S, 60S, 80S and polysomes are indicated.(B) cDNAs were prepared using equal volumes of RNA from each of the 16 sucrose gradient fractions. Clc-1 mRNA distribution in each fraction derived from wild type, Mbnl1
ΔE3/ΔE3
, Mbnl3
ΔE2
, and Mbnl1 suggest that Clc-1 expression is regulated at the translational level and that both Mbnl1 and Mbnl3 are required for optimal Clc-1 mRNA translation. Recent study has demonstrated that depletion of Mbnl proteins leads to misregulation of alternative polyadenylation (APA) events (Batra et al., 2014) and another study has reported that depletion of Mbnl1 and 2 results in mislocalization of many mRNA (Wang et al., 2012) , implicating the Mbnl proteins in regulation of APA and localization of mRNAs. As these events could impact translation, we checked whether poly(A) site shifts occurred in Clc-1 mRNA in Mbnl1
We identified a novel proximal poly(A) start site in the 3′ UTR of Clc-1 gene and a distal poly(A) start site downstream of the Clc-1 3′ UTR both by restriction enzyme digestion and sequencing (Figs. S9 & S10) . However, no significant poly(A) site shift was observed in Mbnl1
ΔE2 skeletal muscles when compared to wild type muscles (Fig. S11 ). Therefore, it is unlikely that the translation defects observed in Mbnl1
ΔE2 skeletal muscles result from alternative poly(A) selection. To test the possibility that mislocalization of Clc-1 mRNA in Mbnl1
ΔE2 skeletal muscles leads to a translation defect, we measured the relative Clc-1 mRNA levels in subcellular fractions that were isolated from wild type and Mbnl1
ΔE3/ΔE3
/Mbnl3 ΔE2 skeletal muscles. However, we observed no significant difference in the Clc-1 mRNA levels in the nuclear, cytoplasmic and membrane fractions from wild type and Mbnl1
ΔE3/ ΔE3
/Mbnl3 ΔE2 mice (Fig. S12) .
3.14. Mbnl1 and Mbnl3 Bind Clc-1 mRNA
We analyzed Clc-1 mRNA sequences to identify the putative Mbnl1 and Mbnl3 binding sites by using SFmap (Akerman et al., 2009; Ho et al., 2004; Paz et al., 2010; Poulos et al., 2013) . We identified 21 and 34 binding sites in the coding region, whereas only 2 and 3 binding sites were found in 3′ UTR for Mbnl1 and Mbnl3, respectively (Fig. S3A) . We then determined whether Mbnl1 and Mbnl3 directly binds Clc-1 mRNAs (3545nts) by using in vitro RNA binding assays.
32 P-labeled Clc-1 (1-1994), Clc-1 (1945-3545) and
Clc-1 (3′ UTR) transcripts showed similar binding to recombinant His-Mbnl1 and His-Mbnl3, but not to GST. As expected, however, 32 P-labeled Clc-1 (3′ UTR) transcripts showed very weak binding to Mbnl1 and Mbnl3 proteins when compared to Clc-1 (1-1994) and Clc-1 (1945-3545) transcripts (Fig. S13B ). Neither His-Mbnl1 nor His-Mbnl3 bound to 32 P-labeled Gapdh transcripts, indicating that the binding between Clc-1 mRNA and Mbnl1 and Mbnl3 is specific (Fig. 7A) .
Mbnl1 and Mbnl3
Demonstrate RNA Regulated Association with Hsp70 and eEF1A
As we observed that the depletion of Mbnl1 and Mbnl3 results in Clc-1 mRNA accumulation in monosomes and the first polysome fractions (Fig. 6) , we tested if these proteins act as adaptors to recruit factors required for translation. To identify proteins associated with Mbnl3, we established cell lines that stably express Flag-tagged Mbnl3. We then purified and identified Mbnl3-associated factors by Mass spectrometry analysis (Fig. 7B) . The identified Mbnl3-associated factors were compared with the Mbnl1-associated factors (Paul et al., 2011) . We found that two factors, Hsp70 and eEF1A, associate with both Mbnl1 (Fig. S14) and Mbnl3 (Fig. 7B ) and the interaction of these factors with Mbnl1 and Mbnl3 was validated by coimmunoprecipitation ( Fig. 7C & D) . To check whether RNA mediates these interactions, we performed coimmunoprecipitation assays both in the presence and absence of RNase A. Interestingly, the interaction between Hsp70 and Mbnl1 and Mbnl3 increased in the presence of RNase A. A similar increase in the interaction between eEF1A and both Mbnl1 and Mbnl3 was observed in the presence of RNase A (Fig. 7C & D) . Our data suggest that the Mbnl proteins may behave as adaptors that serve to recruit protein cargoes to target RNAs. Proteins bound to Mbnl 1 and Mbnl3, which either remains bound to the Mbnl proteins upon target RNA binding or that are released at the site of target RNA binding, can serve to increase the local concentration of these proteins at the site of target RNA binding. To test this idea, we performed coimmunoprecipitation assays in the presence of added CUG repeat-encoding RNAs, which are known to strongly bind both the Mbnl1 and the Mbnl3 proteins. We observed that binding of Hsp70 to the Mbnl proteins decreases as the amount of the CUG transcripts increase (Fig. 7E & F) . Binding to Hsp70 decreased more sharply for Mbnl3 when compared to Mbnl1 in the presence of CUG repeats (Fig. 7E & F) . Thus the enhanced interaction between the cargo protein, Hsp70 and Mbnl1 and Mbnl3 in the presence of RNase may reflect such reversible and competitive binding. The kinetics of cargo protein release may however be influenced by the binding affinity or location of the binding sites on the target RNAs. These results suggest that Hsp70 and Mbnl-target RNAs bind reversely and competitively to Mbnl protein. As both Mbnl1 and Mbnl3 bind Clc-1 mRNAs and depletion of these proteins results in an accumulation of Clc-1 mRNA with monosomes and the first polysome fractions, our data suggests that Mbnl1 and Mbnl3 binding to Clc-1 mRNA engaged in ribosomes may facilitate an increase in the local concentration of Hsp70 and eEF1A to enhance translation (Fig. 7G ).
Discussion
To test the role of the Mbnl family of proteins in skeletal muscle function we have developed and examined transgenic mouse strains that show single and combinatorial deficits in the three muscleblind proteins, Mbnl1, Mbnl2 and Mbnl3. In contrast with the Mbnl1 ΔE3/ΔE3 mice, which have previously been described to recapitulate some features of DM1 muscle disease (Kanadia et al., 2003) The muscleblind protein family encodes two pairs of zinc fingers, each containing three cysteines and one histidine residue, with other regions being conserved to varying degrees (Fardaei et al., 2002) . These proteins show specialized patterns of expression, with MBNL1 levels remaining unchanged during myoblast differentiation and MBNL2 and MBNL3 levels showing elevated expression in myoblasts and diminishing with differentiation (Holt et al., 2009 ). Mbnl1 and Mbnl2 RNAs are detected in adult muscle, heart, brain, kidney, liver and pancreas. Mbnl3 RNA expression is low in adult tissues (Fardaei et al., 2002) . All three proteins sequester strongly in CUG foci in DM1 cells (Fardaei et al., 2002) .
As we do not observe significant mortality in litters derived from Mbnl1 +/ΔE3 X Mbnl2 +/GT2 crosses, our data support the model that combinatorial deficits of Mbnl1 and Mbnl2 results in an embryonic lethal phenotype. These data are reminiscent of the high rate of fetal loss resulting from spontaneous abortion that is documented in DM1 (Jaffe et al., 1986) . Thus complete sequestration of the MBNL1 and MBNL2 proteins in CUG foci may lead to embryonic lethality with less complete sequestration in various cell types and organ systems leading to viable but impaired individuals exhibiting a variety of pathological features (Charizanis et al., 2012; Lee et al., 2013) . Mbnl3 and Mbnl1 loss results in a synergistic interaction manifesting as enhanced myotonia, diminished force production and a histopathology of central nuclei, atrophic fibers and regions of potential fibrosis, in skeletal muscle. These results are particularly intriguing, as Mbnl3 loss does not result in significant muscle pathology. To examine the mechanism underlying this synergy we focused our studies on the 4 to 10 fold enhancement in myotonia observed in the limb muscles of mice lacking Mbnl1 and Mbnl3 when compared to animals lacking only Mbnl1. As previous studies have implicated chloride current deficits in the development of myotonia in the HSA LR mouse model and mice muscles can reflect events resulting from Mbnl3 loss, which may in Previous studies have demonstrated that unlike the truncated 27 kDa Mbnl3 isoform, the full-length 38 kDa Mbnl3 isoform cofractionates with polysomes (Poulos et al., 2013) . In this study, we observe that a fraction of the Mbnl1 protein also cofractionates with polysomes. These observations suggested that the enhanced reduction of Clc-1 function in Mbnl1 ΔE3/ΔE3 /Mbnl3 ΔE2 muscles may result from The translation defects observed for the Clc-1 mRNA appear to be specific as similar alterations were not observed for the Gapdh mRNA. Consistent with this idea, we observe that Mbnl1 and Mbnl3 specifically bind to the Clc-1 mRNA when examined using in vitro RNA binding assays. As depletion of either Mbnl1 or Mbnl3 does not show the prominent defects in Clc-1 RNA distribution on polysome fractions observed in muscles lacking both proteins, it is likely that Mbnl1 and Mbnl3 may have partially redundant functions in Clc-1 mRNA translation regulation. It is therefore conceivable that translation related factors associated with both Mbnl1 and Mbnl3 could be involved in the translation regulation of the Clc-1 mRNA.
In the next set of experiments we identified Hsp70 and eEF1A as Mbnl1 and Mbnl3-interacting factors. These results are significant because Hsp70 is known to play a key role in protein synthesis by association with nascent polypeptides (Beckmann et al., 1990) . As the nascent polypeptide chain emerges into the cytosol, interaction with Hsp70 is crucial for the continuous transport of the polypeptide through the ribosome channel into the cytosol (Nelson et al., 1992) . Hsp70 deficits can therefore cause the nascent polypeptide to interfere with translation by clogging the ribosome channel. Thus Hsp70 deficits can perturb protein synthesis at the translocation step, which can result in reduced accessibility of the EF1A-aminoacyl-tRNA complex to the ribosome (Nelson et al., 1992) . In this context, it is interesting to speculate on the mechanism by which Clc-1 expression is regulated in Mbnl1 ΔE3/ ΔE3 /Mbnl3 ΔE2 muscles. As Mbnl1 and Mbnl3 bind Clc-1 mRNA specifically and because the interaction between Mbnl1 and Mbnl3 with Hsp70 and eEF1A increases subsequent to treatment of RNase A or an increase in the concentration of CUG repeat encoding transcripts, Mbnl1 and Mbnl3 may act as adaptors, that serve to increase the local concentration of Hsp70 and eEF1A on Clc-1 mRNAs engaged with ribosomes ( Fig. 7C-G) . Therefore, Mbnl1 and Mbnl3 depletion can result in the reduction of the local concentration of Hsp70 and eEF1A and consequently shift the Clc-1 mRNA distribution towards the lighter polysome fractions. As these events may serve to shift the equilibrium towards less efficient translation rather than a complete stalling of translation, they can provide an explanation for the increase in the frequency with which muscle fibers with low chloride currents are encountered in Mbnl1
/Mbnl3 ΔE2 muscles. Taken together our data demonstrate that Mbnl1 and Mbnl3 deficits profoundly enhance myotonia and that the mechanisms driving this enhancement are not only Clc-1 splice errors resulting from Mbnl1 loss, but also Clc-1 translation defects occurring from the dual loss of Mbnl1 and Mbnl3. Importantly, as both Clc-1 splice defects and an aberrant accumulation of Clc-1 RNA on monosomes and the first polysomes is observed in the HSA LR DM1 model, where a similar increase in a subpopulation of muscle fibers with low chloride currents has been reported (DiFranco et al., 2013) , our data demonstrate that splice defects work coordinately with translation errors for key features of myotonic dystrophy pathology to fully manifest.
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